FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W144291087> ?p ?o ?g. }

• W144291087 endingPage "1091" @default.
• W144291087 startingPage "1083" @default.
• W144291087 abstract "Aprotinin reduces blood loss after cardiopulmonary bypass, but may sensitize recipients and is expensive. Tranexamic acid, a synthetic antifibrinolytic, has less disadvantages, but opinions differ regarding its efficacy. We studied three groups of patients undergoing cardiopulmonary bypass for coronary disease: recipients of aprotinin (total dose 4.2 x 10(6) kallikrein inhibiting units, n = 14), recipients of tranexamic acid (total dose 20 mg/kg body weight, n = 15), and nonmedicated controls (n = 14) during 24 hours after cardiopulmonary bypass. Compared with controls, aprotinin reduced blood loss, the number of patients requiring transfusions, and the mean number of transfused red cell units (all with p < 0.05), whereas the recipients of tranexamic acid did not differ either from aprotinin recipients or from controls. Aprotinin and tranexamic acid both mitigated the early postoperative reduction of adenosine diphosphate-induced platelet aggregation seen in the controls (p < 0.05). Postoperative increases of plasma concentrations of the prothrombin activation fragment F1 + 2 and the thrombin-antithrombin III complex showed an activation of intravascular coagulation, without any intergroup differences. The balance between concentrations of tissue plasminogen activator and the type 1 plasminogen activator inhibitor disclosed an activation of fibrinolysis, without differences between the groups. The concentrations of D-dimer, a breakdown product of cross-linked fibrin, remained at baseline in the recipients of aprotinin and tranexamic acid but tripled in the controls (p < 0.05). By contrast, the plasma antiplasmin activity was equally depressed in the tranexamic acid and the control groups but decreased less in the recipients of aprotinin (p < 0.05). This discrepancy may reflect the different modes of action of the two agents, which may make aprotinin more efficacious than tranexamic acid in the nonfibrinolytic act of protecting platelet function against attack by plasmin during cardiopulmonary bypass." @default.
• W144291087 created "2016-06-24" @default.
• W144291087 creator A5004237078 @default.
• W144291087 creator A5026292383 @default.
• W144291087 creator A5053537794 @default.
• W144291087 creator A5056200970 @default.
• W144291087 creator A5074378922 @default.
• W144291087 creator A5077475178 @default.
• W144291087 date "1994-12-01" @default.
• W144291087 modified "2023-10-17" @default.
• W144291087 title "Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass" @default.
• W144291087 cites W12076958 @default.
• W144291087 cites W127580824 @default.
• W144291087 cites W133116715 @default.
• W144291087 cites W1510327059 @default.
• W144291087 cites W1516463094 @default.
• W144291087 cites W163257244 @default.
• W144291087 cites W177712551 @default.
• W144291087 cites W1912205460 @default.
• W144291087 cites W1963559816 @default.
• W144291087 cites W1966733064 @default.
• W144291087 cites W1967171077 @default.
• W144291087 cites W1967298175 @default.
• W144291087 cites W1970202121 @default.
• W144291087 cites W1978039741 @default.
• W144291087 cites W2002116330 @default.
• W144291087 cites W2004736807 @default.
• W144291087 cites W2009699612 @default.
• W144291087 cites W2012214760 @default.
• W144291087 cites W2025933862 @default.
• W144291087 cites W2032895952 @default.
• W144291087 cites W2035824276 @default.
• W144291087 cites W2050483671 @default.
• W144291087 cites W2051866170 @default.
• W144291087 cites W2055337224 @default.
• W144291087 cites W2062839391 @default.
• W144291087 cites W2070586531 @default.
• W144291087 cites W2070702305 @default.
• W144291087 cites W2071688536 @default.
• W144291087 cites W2076434776 @default.
• W144291087 cites W2092290419 @default.
• W144291087 cites W2094207770 @default.
• W144291087 cites W2105423629 @default.
• W144291087 cites W2114332148 @default.
• W144291087 cites W2118414830 @default.
• W144291087 cites W2147929076 @default.
• W144291087 cites W2149769366 @default.
• W144291087 cites W2156910916 @default.
• W144291087 cites W2253816243 @default.
• W144291087 cites W2276402466 @default.
• W144291087 cites W2399495832 @default.
• W144291087 cites W2406020410 @default.
• W144291087 cites W2408933653 @default.
• W144291087 cites W2408971219 @default.
• W144291087 cites W2411817626 @default.
• W144291087 cites W2412534193 @default.
• W144291087 cites W2413550399 @default.
• W144291087 cites W2414491935 @default.
• W144291087 cites W2416111847 @default.
• W144291087 cites W2416703949 @default.
• W144291087 cites W2417677669 @default.
• W144291087 cites W2468086690 @default.
• W144291087 cites W2469316347 @default.
• W144291087 cites W3021384959 @default.
• W144291087 cites W4293504266 @default.
• W144291087 doi "https://doi.org/10.1016/s0022-5223(12)70192-7" @default.
• W144291087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7527112" @default.
• W144291087 hasPublicationYear "1994" @default.
• W144291087 type Work @default.
• W144291087 sameAs 144291087 @default.
• W144291087 citedByCount "123" @default.
• W144291087 countsByYear W1442910872012 @default.
• W144291087 countsByYear W1442910872013 @default.
• W144291087 countsByYear W1442910872015 @default.
• W144291087 crossrefType "journal-article" @default.
• W144291087 hasAuthorship W144291087A5004237078 @default.
• W144291087 hasAuthorship W144291087A5026292383 @default.
• W144291087 hasAuthorship W144291087A5053537794 @default.
• W144291087 hasAuthorship W144291087A5056200970 @default.
• W144291087 hasAuthorship W144291087A5074378922 @default.
• W144291087 hasAuthorship W144291087A5077475178 @default.
• W144291087 hasBestOaLocation W1442910871 @default.
• W144291087 hasConcept C126322002 @default.
• W144291087 hasConcept C141071460 @default.
• W144291087 hasConcept C181199279 @default.
• W144291087 hasConcept C185592680 @default.
• W144291087 hasConcept C203014093 @default.
• W144291087 hasConcept C2776825266 @default.
• W144291087 hasConcept C2778881276 @default.
• W144291087 hasConcept C2779637338 @default.
• W144291087 hasConcept C2779679481 @default.
• W144291087 hasConcept C2780799893 @default.
• W144291087 hasConcept C2781071845 @default.
• W144291087 hasConcept C2781436528 @default.
• W144291087 hasConcept C2991743468 @default.
• W144291087 hasConcept C42219234 @default.
• W144291087 hasConcept C54173615 @default.
• W144291087 hasConcept C55493867 @default.

• next